Genetic variation in Otos is associated with cisplatin-induced ototoxicity

The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin-Induced Ototoxicity in Children With Cancer

(2013) J J Yang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children

(2013) K Pussegoda et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cisplatin-induced Ototoxicity in Pediatric Solid Tumors

(2013) Worawut Choeyprasert et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting

(2012) T Harris et al.   JOURNAL OF LARYNGOLOGY AND OTOLOGY

Gene Therapy for Cisplatin-Induced Ototoxicity

(2012) Sofia Waissbluth et al.   OTOLOGY & NEUROTOLOGY

Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer

(2011) Mette Sprauten et al.   JOURNAL OF CLINICAL ONCOLOGY

Pharmacogenomics of cisplatin-induced ototoxicity

(2011) Debashree Mukherjea et al.   PHARMACOGENOMICS

Practical Grading System for Evaluating Cisplatin Ototoxicity in Children

(2010) Kay W. Chang et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

(2009) Colin J D Ross et al.   NATURE GENETICS

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

(2009) D Caronia et al.   PHARMACOGENOMICS JOURNAL

Is otospiralin inner ear specific? Evidence for its expression in mouse brain

(2008) Boris Decourt et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE

Adenoviral-mediated up-regulation of Otos, a novel specific cochlear gene, decreases cisplatin-induced apoptosis of cultured spiral ligament fibrocytes via MAPK/mitochondrial pathway

(2008) Xian-Lu Zhuo et al.   TOXICOLOGY